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An intrafamilial outbreak in West Bengal, India, 
involving 5 deaths and person-to-person transmission was 
attributed to Nipah virus. Full-genome sequence of Nipah 
virus (18,252 nt) amplifi ed from lung tissue showed 99.2% 
nt and 99.8% aa identity with the Bangladesh-2004 isolate, 
suggesting a common source of the virus.
Nipah virus (NiV) causes encephalitis or respiratory signs and symptoms in humans, with high death rates 
(1–4). NiV outbreaks have been reported from Malaysia, 
Bangladesh, Singapore, and India (1,5–13). Cases in 
humans have been attributed to zoonotic transmission from 
pigs and bats (1,14). We describe a full genome sequence 
of NiV from an outbreak in India.
The Study
During April 9–28, 2007, fi ve persons became ill and 
died within a few days at village Belechuapara, Nadia 
district, West Bengal, India, which borders Bangladesh. 
The index case-patient (case-patient 1) was a 35-year-
old male farmer addicted to country liquor derived from 
palm juice. Hundreds of bats were observed hanging from 
the trees around his residence, which strongly suggested 
association with the infection of the index case-patient and 
possibility of contamination of the liquor with bat excreta 
or secretions.
Three patients were close relatives of case-patient 1: 
his 25-year-old brother (case-patient 2), his 30-year-old 
wife (case-patient 3), and his 39-year-old brother-in-law 
(case-patient 4). They became ill 12, 14, and 14 days, 
respectively, after contact with case-patient 1. In another 
person, a 28-year-old man (case-patient 5) who collected 
blood samples from and performed a computed tomography 
scan of the brain of case-patient 1, symptoms developed 12 
days after contact.
No samples were available from the fi rst 2 case-
patients. Brain and lung tissues from case-patient 3, 
cerebrospinal fl uid (CSF) from case-patient 4, and urine 
and CSF from case-patient 5 were collected. Blood samples 
were obtained from case-patients 4 and 5 and from 34 
asymptomatic contacts from the village. Serum samples 
from these persons were tested for immunoglobulin (Ig) M 
and IgG antibodies to NiV (IgM/IgG anti-NiV) with ELISA 
by using reagents provided by the Centers for Disease 
Control and Prevention (Atlanta, GA, USA). To detect NiV 
RNA, urine (250 μL), CSF (100 μL), or autopsied brain or 
lung tissue (100 mg) were used, and RNA was extracted 
by using TRIzol LS and TRIzol reagents (Invitrogen 
Life Technologies, Carlsbad, CA, USA). Nested reverse 
transcription–PCR (RT-PCR) was conducted by using 
nucleocapsid (N) gene–based primers (8).
Attempts to isolate NiV in Vero E6 cell lines or infant 
mice were unsuccessful. The full-length genomic sequence 
was obtained from the lung of case-patient 3 by using 36 
sets of primers (online Appendix Table, www.cdc.gov/
EID/content/17/5/907-appT.htm), Superscript II RNase 
reverse transcriptase for reverse transcription (Invitrogen), 
and Pfx polymerase for amplifi cation (Invitrogen). The 
PCR products of predicted molecular size were gel eluted 
(QIAquick PCR Purifi cation Kit; QIAGEN, Hilden, 
Germany) and sequenced by using BigDye Terminator 
cycle sequencing Ready Reaction Kit (Applied Biosystems, 
Foster City, CA, USA) and an automatic Sequencer (ABI 
Prism 3100 Genetic Analyzer; Applied Biosystems). PCR 
products were sequenced in both directions. To determine 
the genotypic status, phylogenetic analysis was conducted 
by using partial N gene and full NiV genome sequences 
with the Kimura 2-parameter distance model and neighbor-
joining method available in MEGA version 3.1 software 
(www.megasoftware.net). The reliability of phylogenetic 
groupings was evaluated by the bootstrap test with 1,000 
bootstrap replications.
Patients’ signs and symptoms included high fever 
(103°F–105°F [39.4°C–49.6°C]) with and without chills, 
severe occipital headache, nausea, vomiting, respiratory 
distress, pain in calf muscles, slurred speech, twitching 
of facial muscles, altered sensorium, (focal) convulsions, 
unconsciousness, coma, and death. The fi rst 3 case-patients 
died within 2–3 days after symptom onset; case-patients 
4 and 5 died after 5 and 6 days, respectively. Clinical 
investigations could be conducted for case-patients 4 and 
5. Results of serologic tests for malaria parasite, typhoid, 
anti-dengue IgM, HIV, and hepatitis B surface antigen 
were negative. Peripheral blood profi les were within 
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reference limits. Alanine aminotransferase, aspartate 
aminotransferase, creatine phosphokinase, and C-reactive 
protein were elevated. Blood gas analysis in case-patient 
4 (case-patient 5 values in parentheses) showed oxygen 
saturation 49.4% (71%), pO2 36.1 mm Hg (44.8 mm Hg), 
pCO2 44.4mm Hg (44.1 mm Hg), HCO3 15.7 mmol/L 
(19.1 mmol/L), and pH 7.166 (7.255). Lumbar puncture of 
case-patient 5 showed opening pressure within reference 
range (1 drop/second), 2 cells/cm; all cells observed were 
lymphocytes. Chest radiograph indicated pulmonary 
edema, which suggested acute respiratory distress 
syndrome. At the time of admission, computed tomography 
and magnetic resonance imaging scans of the brain showed 
no abnormality.
Serum samples from case-patients 4 and 5 were positive 
for IgM anti-NiV. Of the clinical samples screened, brain 
and lung tissues of case-patient 3, CSF of case-patient 4, 
and urine of case-patient 5 were NiV RNA positive. Of the 
34 asymptomatic contacts, 1 was positive for IgG anti-NiV 
and negative for IgM anti-NiV and did not report any major 
illness in the past. This positivity may refl ect a previous 
subclinical infection or cross-reactivity in ELISA needing 
further follow-up.
Before this report, similar cases had not been reported 
from the village or the surrounding area. Partial N gene 
sequences confi rmed NiV in the clinical specimens from all 
3 case-patients. Phylogenetic analysis showed that similar 
to fi ndings from the 2001 outbreak study (8), viruses from 
Bangladesh and India clustered and diverged from the 
viruses from Malaysia. (Figure, panel A). The length of the 
full genome of the isolate from India was 18,252 nt. The 
sequence of this virus (INDNipah-07–1, GenBank accession 
no. FJ513078) was closer to the virus from Bangladesh 
(Figure, panel B), with 99.2% (151 nt substitutions) and 
99.80% (17 aa substitutions) identity at nucleotide and 
amino acid levels respectively. Of the 151 nt substitutions, 
9 occurred in the N open reading frame (ORF),11 in the 
phosphoprotein ORF, 8 in the matrix ORF, 11 in the fusion 
glycoprotein ORF, 7 in the attachment protein ORF, and 
47 in the large polymerase ORF. Fifty-eight substitutions 
occurred in nontranslated regions at the beginning and the 
end of each ORF. The intergenic sequences between gene 
boundaries were highly conserved in the isolate from India, 
compared with the isolate from Bangladesh, which showed 
1 change (GAA to UAA) between the attachment protein 
and large polymerase genes. No change was observed in 
the leader and the trailer sequences.
The Table compares amino acid substitutions in the 
different regions of the genome of the isolate from India with 
those of the viruses from Bangladesh and Malaysia. Of the 
17 aa substitutions, 7 were unique to the isolate from India, 
and 10 were similar to the isolates from Malaysia. Overall, 
however, the isolate from India was closer to the isolate from 
Bangladesh, although distinct differences were observed.
To our knowledge, this is the second report of an 
NiV outbreak in India, identifi ed within 1 week of the 
investigation. The fi rst outbreak affected mainly hospital 
staff or persons visiting hospitalized patients; the 74% 
case-fatality rate strongly suggested person-to-person 
transmission (8). Both outbreaks (2001 and 2007) occurred 
in the state of West Bengal bordering Bangladesh wherein 
several outbreaks of the disease have been reported (7,9–
13). However, fruit bats from West Bengal have not been 
screened for evidence of NiV infection. This state needs 
to create awareness about NiV and obligatory testing of 
suspected case-patients.
Conclusions
NiV caused an intrafamilial outbreak with a 100% 
case-fatality rate, which confi rmed person-to-person 
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Figure. A) Phylogenetic analysis based on partial nucleocapsid (N) 
gene nucleotide sequences (159 nt, according to Nipah virus [NiV] 
Bangladesh sequence, GenBank accession no. AY988601, 168–
327 nt) of the 4 NiVs sequenced during this study (boldface). Five 
sequences of the viruses from Siliguri (8) and from representative 
NiV sequences obtained from GenBank indicated by the respective 
accession numbers. Values at different nodes denote bootstrap 
support. B) Full genome–based phylogenetic analysis of the 
NiV sequenced from the lung tissue of a patient (boldface). 
Representative NiV sequences obtained from GenBank are 
indicated by the respective accession numbers. Values at different 
nodes denote bootstrap support. Scale bars indicate nucleotide 
substitutions per site.
Genomic Characterization of Nipah Virus
transmission. The NiV strains from India and Bangladesh 
were closer than the Malaysian viruses. Although the 
outbreaks occurred in neighboring geographic areas, NiV 
outbreaks in Bangladesh and India were not caused by the 
same virus strain or by spillover.
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Table. Regionwise amino acid substitutions in the Nipah virus 
genome* 
Region and amino acid 
position India Bangladesh Malaysia 
Phosphoprotein 
 228 K R R
 276 S G G
 285 R H R
 310 R G G
Nucleocapsid protein 
 188 E D E
 211 R Q Q
Matrix protein 
 13 I M M
Fusion protein 
 19 I M M
 207 L S L
 252 D G D
Attachment protein 
 304 V I I
Large polymerase protein 
 94 I T I
 112 K R K
 632 N S N
 639 N D N
 665 T I T
 1748 I V I
*GenBank accession numbers of isolates examined: India (FJ513078), 
Bangladesh (AY988601), and Malaysia (AY029767,AY029768, and 
AJ564623). Boldface indicates unique amino acids in the isolate from 
India. 
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